SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Burkhard Brinkmann who wrote (248)7/20/1996 6:22:00 PM
From: Rick Costantino   of 4342
 
Thnaks for the post. It looks like Paracelsian is finally getting
some largert recognition.

It is unfortunate that the article makes it sound like the drug
PN355 is still pre-clinical ("in the lab"). They did not bother to
mention that it is in Phase I clinical trials (and that the anticancer
drug looks proimising in compassionate use trials.

Maybe other journals will also start following PRLN?

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext